Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Biotechnology company Intellia Therapeutics announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on its Phase 3 Magnitude trial for transthyretin amyloid cardiomyopathy (ATTR-CM).

Biotechnology company Intellia Therapeutics announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on its Phase 3 Magnitude trial for transthyretin amyloid cardiomyopathy (ATTR-CM).

老虎证券老虎证券2026/03/02 12:41
Show original
This decision means that this important clinical research project will be restarted and continue to move forward.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BP (BP.US) sells Castrol shares for $6 billions to repay debt, Stonepeak acquires 65%

BP completed the sale of a 65% stake in its Castrol lubricants business to the American private equity firm Stonepeak Partners on Monday.

智通财经•2026/11/02 08:22